Should You Accumulate Cerevel Therapeutics Holdings Inc (CERE) Stock Tuesday?

Cerevel Therapeutics Holdings Inc (CERE) stock is higher by 112.88% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CERE stock a score of 72 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 92. CERE's rank also includes a long-term technical score of 83. The fundamental score for CERE is 40. In addition to the average rating from Wall Street analysts, CERE stock has a mean target price of $47.50. This means analysts expect the stock to climb 45.17% over the next 12 months.

CERE has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CERE!

See Full CERE Report

What's Happening with CERE Stock Today

Cerevel Therapeutics Holdings Inc (CERE) stock has gained 3.87% while the S&P 500 is higher by 1.23% as of 2:15 PM on Tuesday, Apr 19. CERE is higher by $1.22 from the previous closing price of $31.50 on volume of 113,096 shares. Over the past year the S&P 500 has risen 6.78% while CERE is higher by 112.88%. CERE lost -$1.65 per share in the over the last 12 months. Click Here to get the full Stock Report for Cerevel Therapeutics Holdings Inc stock.